ECS Botanics Secures $1.75m supply agreement in New Zealand
- ECS Botanics (ECS) secures a four year agreement with one of New Zealand’s largest cannabis distribution companies
- The new deal with MW Pharma will see the company supply ECS medicinal cannabis products, generating a minimum $1.5 million in revenue
- The product will be white labelled across existing brands and sold through MW Pharma’s established relationships with New Zealand’s pharmacy networks
- Under the deal, the minimum order value will be $250,000 with a minimum $500,000 over the following three years
- ECS says it aims to increase the sale of its cannabis production this season, with several additional contracts in their final stages
- ECSBotanics was up 2.94 per cent, trading at 3.5 cents at 1:45 pm AEST
